当前位置: X-MOL 学术Cell Death Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
TGR5 supresses cGAS/STING pathway by inhibiting GRP75-mediated endoplasmic reticulum-mitochondrial coupling in diabetic retinopathy
Cell Death & Disease ( IF 8.1 ) Pub Date : 2023-09-01 , DOI: 10.1038/s41419-023-06111-5
Yan Li 1 , Lingpeng Zhu 1, 2 , Meng-Xia Cai 1 , Zi-Li Wang 1 , Miao Zhuang 1 , Cheng-Ye Tan 1 , Tian-Hua Xie 1 , Yong Yao 1 , Ting-Ting Wei 1, 2
Affiliation  

Diabetic retinopathy (DR) is a serious and relatively under-recognized complication of diabetes. Müller glial cells extend throughout the retina and play vital roles in maintaining retinal homeostasis. Previous studies have demonstrated that TGR5, a member of the bile acid-activated GPCR family, could ameliorate DR. However, the role of TGR5 in regulating Müller cell function and the underlying mechanism remains to be ascertained. To address this, high glucose (HG)-treated human Müller cells and streptozotocin-treated Sprague-Dawley rats were used in the study. The IP3R1-GRP75-VDAC1 axis and mitochondrial function were assessed after TGR5 ablation or agonism. Cytosolic mitochondrial DNA (mtDNA)-mediated cGAS-STING activation was performed. The key markers of retinal vascular leakage, apoptosis, and inflammation were examined. We found that mitochondrial Ca2+ overload and mitochondrial dysfunction were alleviated by TGR5 agonist. Mechanically, TGR5 blocked the IP3R1-GRP75-VDAC1 axis mediated Ca2+ efflux from the endoplasmic reticulum into mitochondria under diabetic condition. Mitochondrial Ca2+ overload led to the opening of the mitochondrial permeability transition pore and the release of mitochondrial DNA (mtDNA) into the cytosol. Cytoplasmic mtDNA bound to cGAS and upregulated 2’3’ cyclic GMP-AMP. Consequently, STING-mediated inflammatory responses were activated. TGR5 agonist prevented retinal injury, whereas knockdown of TGR5 exacerbated retinal damage in DR rats, which was rescued by the STING inhibitor. Based on the above results, we propose that TGR5 might be a novel therapeutic target for the treatment of DR.



中文翻译:

TGR5 通过抑制糖尿病视网膜病变中 GRP75 介导的内质网-线粒体偶联来抑制 cGAS/STING 通路

糖尿病视网膜病变(DR)是一种严重且相对未被充分认识的糖尿病并发症。米勒胶质细胞遍布整个视网膜,在维持视网膜稳态方面发挥着重要作用。先前的研究表明,胆汁酸激活的 GPCR 家族成员 TGR5 可以改善 DR。然而,TGR5在调节Müller细胞功能中的作用及其潜在机制仍有待确定。为了解决这个问题,研究中使用了高葡萄糖 (HG) 处理的人类 Müller 细胞和链脲佐菌素处理的 Sprague-Dawley 大鼠。TGR5 消融或激动后评估 IP3R1-GRP75-VDAC1 轴和线粒体功能。进行了胞质线粒体 DNA (mtDNA) 介导的 cGAS-STING 激活。检查了视网膜血管渗漏、细胞凋亡和炎症的关键标志物。我们发现TGR5激动剂减轻了线粒体Ca 2+超载和线粒体功能障碍。从机械角度来说,在糖尿病条件下,TGR5 阻断了 IP3R1-GRP75-VDAC1 轴介导的 Ca 2+从内质网流出到线粒体。线粒体Ca 2+超载导致线粒体通透性转换孔打开并将线粒体DNA (mtDNA) 释放到细胞质中。细胞质 mtDNA 与 cGAS 结合并上调 2'3' 环 GMP-AMP。因此,STING 介导的炎症反应被激活。TGR5 激动剂可以预防视网膜损伤,而 TGR5 的敲除会加剧 DR 大鼠的视网膜损伤,而 STING 抑制剂可以挽救这种损伤。基于以上结果,我们提出TGR5可能成为治疗DR的新治疗靶点。

更新日期:2023-09-02
down
wechat
bug